These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38673014)

  • 21. Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Ari E; Yilmaz Y; Gul A; Alahdab YO; Kedrah AE; Macunluoglu B; Aydin A; Arikan H; Ozener C
    Am J Reprod Immunol; 2009 Oct; 62(4):238-42. PubMed ID: 19703145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.
    Yonekura Collier AR; Zsengeller Z; Pernicone E; Salahuddin S; Khankin EV; Karumanchi SA
    Hypertens Pregnancy; 2019 Aug; 38(3):193-199. PubMed ID: 31291799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.
    Vaught AJ; Gavriilaki E; Hueppchen N; Blakemore K; Yuan X; Seifert SM; York S; Brodsky RA
    Exp Hematol; 2016 May; 44(5):390-8. PubMed ID: 26921648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome Levels and Activity in Pregnancies Complicated by Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Thrombocytopenia (HELLP) Syndrome.
    Berryman K; Buhimschi CS; Zhao G; Axe M; Locke M; Buhimschi IA
    Hypertension; 2019 Jun; 73(6):1308-1318. PubMed ID: 31067191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case Report.
    Lokki AI; Haapio M; Heikkinen-Eloranta J
    Front Immunol; 2020; 11():548. PubMed ID: 32308654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
    Fischer T; Schneider MP; Schobel HP; Heusser K; Langenfeld M; Schmieder RE
    Am J Obstet Gynecol; 2000 Dec; 183(6):1489-94. PubMed ID: 11120516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies.
    Williams KP; Galerneau F
    J Obstet Gynaecol Can; 2002 Aug; 24(8):628-32. PubMed ID: 12196841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia.
    Aref S; Goda H
    Hematology; 2013 Jul; 18(4):237-41. PubMed ID: 23433535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Haeger M; Unander M; Bengtsson A
    Obstet Gynecol; 1990 Oct; 76(4):698-702. PubMed ID: 2216207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Haeger M; Unander M; Andersson B; Tarkowski A; Arnestad JP; Bengtsson A
    Acta Obstet Gynecol Scand; 1996 Sep; 75(8):695-701. PubMed ID: 8906000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
    Kumar M; Cao W; McDaniel JK; Pham HP; Raju D; Nawalinski K; Frangos S; Kung D; Zager E; Kasner SE; Levine JM; Zheng XL
    Thromb Haemost; 2017 Apr; 117(4):691-699. PubMed ID: 28102428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
    Farkas P; Csuka D; Mikes B; Sinkovits G; Réti M; Németh E; Rácz K; Madách K; Gergely M; Demeter J; Prohászka Z
    Immunobiology; 2017 Feb; 222(2):119-127. PubMed ID: 27771173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia.
    Valencia CM; Hersh AR; Burwick RM; Velásquez JA; Gutiérrez-Marín J; Edna F; Silva JL; Trujillo-Otálvaro J; Vargas-Rodríguez J; Bernal Y; Quintero A; Rincón M; Tolosa JE
    Pregnancy Hypertens; 2022 Aug; 29():92-97. PubMed ID: 35820290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of hepatic artery resistance to blood flow in preeclampsia in presence or absence of HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets).
    Oosterhof H; Voorhoeve PG; Aarnoudse JG
    Am J Obstet Gynecol; 1994 Aug; 171(2):526-30. PubMed ID: 8059835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Alterations in Complement Alternative Pathway and Related Genetic Analysis in Severe Phenotype Preeclampsia.
    Alrahmani L; Gonzalez Suarez ML; Cousin MA; Moyer AM; Willrich MAV; White WM; Wick MJ; Tostrud LJ; Narang K; Garovic VD
    Kidney360; 2021 Sep; 2(9):1463-1472. PubMed ID: 35373096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations.
    Sullivan CA; Magann EF; Perry KG; Roberts WE; Blake PG; Martin JN
    Am J Obstet Gynecol; 1994 Oct; 171(4):940-3. PubMed ID: 7943105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the complement system in normal pregnancy and preeclampsia.
    Derzsy Z; Prohászka Z; Rigó J; Füst G; Molvarec A
    Mol Immunol; 2010 Apr; 47(7-8):1500-6. PubMed ID: 20181396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation in relation to development of preeclampsia.
    Haeger M; Unander M; Bengtsson A
    Obstet Gynecol; 1991 Jul; 78(1):46-9. PubMed ID: 2047067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia.
    Alpoim PN; Gomes KB; Godoi LC; Rios DR; Carvalho MG; Fernandes AP; Dusse LM
    Clin Chim Acta; 2011 Nov; 412(23-24):2162-6. PubMed ID: 21840304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.